The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation

Hematological Oncology

Volumn 24, Issue 3, 2006, Pages 164-165

  Abidi, Muneer H ^a   Kozlowski, Jennifer R ^a   Ibrahim, Rami B ^a   Peres, Edward ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Dapsone; Hematopoietic Stem Cell Transplant

Indexed keywords

BUSULFAN; CIDOFOVIR; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAPSONE; FLUCONAZOLE; SULFONAMIDE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EXFOLIATIVE DERMATITIS; FEMALE; FEVER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LABORATORY TEST; METHEMOGLOBINEMIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SULFONE SYNDROME;

ANEMIA, HEMOLYTIC; DAPSONE; DERMATITIS, EXFOLIATIVE; DRUG HYPERSENSITIVITY; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS, TOXIC; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; SULFONAMIDES; SYNDROME; TRANSPLANTATION, HOMOLOGOUS;

EID: 33749252363     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.780     Document Type: Article

References (7)

1. Sangiolo D, Storer B, Nash R, et al. Toxicity and efficacy of daily dapsone as Pneumocystis prophylaxis after hematopoietic stem cell transplantation: a case control study. Biology of Blood and Marrow Transplantation 2005; 11: 521-529.
2. Tomecki KJ, Catalano CJ. Dapsone hypersensitivity: the sulfone syndrome revisited. Arch Dermatol 1981; 117: 38-39.
3. Mohle-Boetani J, Akula SK, Holodniy M, Katzenstein D, Garcia G. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West J Med 1992; 156: 303-306.
4. Johnson DA, Cattau EL, Kuritsky JN, Zimmerman H. Liver involvement in sulfone syndrome. Arch Intern Med 1986; 146: 875-877.
5. Lowe J, Smith M. The chemotherapy of leprosy in Nigeria, with an appendix of glandular fever and exfoliative dermatitis precipitated by sulfones. Int J Leprosy 1949; 17: 181-195.
6. Rege VL, Shukla P, Mascarenhas MF. Dapsone syndrome in Goa. Indian J Leprosy 1994; 66: 59-64.
7. Williams S, MacDonald P, Hoyer JD, Barr RD, Athale UH. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: A correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Pediatric Blood & Cancer 2005; 45: 55-62.